Aprepitant and Vanzacaftor: Interaction Details
- Aprepitant
- EmendCinvantiAponvie
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Aprepitant and Vanzacaftor interaction:
Aprepitant
- Emend
- Cinvanti
- Aponvie
Vanzacaftor
We don't have a separate drug information page for Vanzacaftor. The FDA's drug directory lists it as part of Alyftrek (vanzacaftor, tezacaftor and deutivacaftor). Have a question about Vanzacaftor? Ask a pharmacist, free →
What Happens When You Take Aprepitant With Vanzacaftor
What can happen when they are taken together (rated Major)
Increased vanzacaftor exposure and an increased risk of vanzacaftor-related adverse reactions
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
When vanzacaftor is given together with a moderate , vanzacaftor exposure can rise, and this may raise the risk of adverse reactions associated with vanzacaftor. A drug interaction study gave vanzacaftor 20 mg, tezacaftor 100 mg and deutivacaftor 250 mg once daily along with fluconazole 200 mg daily, a moderate CYP3A inhibitor.
Vanzacaftor increased 2.55-fold and 2.48-fold, while deutivacaftor AUC increased 3.13-fold and Cmax 2.27-fold. The vanzacaftor dosage should be lowered when a moderate CYP3A inhibitor is used at the same time.
In children aged 6 to less than 12 years who weigh less than 40 kg, the dose is adjusted to two tablets of vanzacaftor 4 mg/tezacaftor 20 mg/deutivacaftor 50 mg taken every other day, and for those weighing 40 kg or more, the dose is adjusted to one tablet of vanzacaftor 10 mg/tezacaftor 50 mg/deutivacaftor 125 mg every other day. Patients aged 12 years and older have their dose adjusted to one tablet of vanzacaftor 10 mg/tezacaftor 50 mg/deutivacaftor 125 mg every other day.1
The Aprepitant and Vanzacaftor Interaction, Explained
Aprepitant is used to prevent nausea and vomiting, often with chemotherapy or surgery. Vanzacaftor is one part of a combination cystic fibrosis medicine. Aprepitant slows down an enzyme in your liver () that helps clear vanzacaftor from your body. That can cause more vanzacaftor to build up, which may raise the chance of side effects.
This is a known and manageable interaction. The cystic fibrosis dose is often lowered and individualized when it is taken with a medicine like this. Please don't change anything on your own. Keep taking your medicines as prescribed and check with your pharmacist or doctor, who can adjust the plan and watch you closely.
Mechanism: Aprepitant is a moderate . Vanzacaftor is a CYP3A , so is expected to increase its exposure (no activation involved).
- Magnitude: With fluconazole (moderate CYP3A inhibitor), vanzacaftor rose 2.55-fold and 2.48-fold; deutivacaftor AUC rose 3.13-fold and Cmax 2.27-fold.
- Evidence/onset: Probable; onset unspecified. Data are from a class-representative inhibitor, not aprepitant itself.
- Management: Reduce the vanzacaftor/tezacaftor/deutivacaftor dose. Ages 6 to under 12, under 40 kg: two tablets of 4/20/50 mg every other day; 40 kg or more: one 10/50/125 mg tablet every other day. Age 12 and older: one 10/50/125 mg tablet every other day. Monitor for adverse reactions.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Aprepitant and Vanzacaftor Interact
The likely mechanism
of -mediated of vanzacaftor
How to Manage the Aprepitant and Vanzacaftor Interaction
Your care team can manage this by adjusting the dose of your cystic fibrosis medicine while you take aprepitant.
- The documented approach is a reduced dose taken every other day. The exact tablet strength depends on your age and weight, so your prescriber will tailor it for you.
- Your team may monitor you more closely for side effects.
- Keep taking both medicines as prescribed, and don't change doses yourself.
- Tell your pharmacist or prescriber if you start, stop, or are given aprepitant, and report any new or worsening side effects.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Aprepitant or Vanzacaftor need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: ALYFTREK oral tablets, vanzacaftor, tezacaftor, and deutivacaftor oral tablets
In a drug interaction study, giving vanzacaftor 20 mg, tezacaftor 100 mg, and deutivacaftor 250 mg once daily together with fluconazole 200 mg daily, a moderate , raised the vanzacaftor 2.55-fold and its 2.48-fold. The same also raised the deutivacaftor AUC 3.13-fold and its Cmax 2.27-fold.1
Aprepitant and Vanzacaftor: Common Questions
How serious is the Aprepitant and Vanzacaftor interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Aprepitant and Vanzacaftor interaction managed?
Your care team can manage this by adjusting the dose of your cystic fibrosis medicine while you take aprepitant. The documented approach is a reduced dose taken every other day. The exact tablet strength depends on your age and weight, so your prescriber will tailor it for you. Your team may monitor you more closely for side effects. Keep taking both medicines as prescribed, and don't change doses… Management is individual — always follow your own care team's guidance.
Does taking Aprepitant and Vanzacaftor at different times of day help?
No. Taking them at different times of day does not prevent this one. Aprepitant slows , an enzyme that breaks down vanzacaftor, so vanzacaftor can build up in the body. That change lasts while aprepitant is being taken and can continue for a while after the last dose.
Your pharmacist or prescriber can tell you how they will manage it.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Aprepitant and Vanzacaftor Interaction
Ask in your own words about taking Aprepitant and Vanzacaftor together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: ALYFTREK(R) oral tablets, vanzacaftor, tezacaftor, and deutivacaftor oral tablets. Vertex Pharmaceuticals Incorporated (per FDA), Boston, MA, 2024. DailyMed
Other Serious Interactions of Aprepitant and Vanzacaftor
Also serious with Aprepitant
- FlibanserinContraindicated
- LevoketoconazoleContraindicated
- LomitapideContraindicated
- PimozideContraindicated
Also serious with Vanzacaftor
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Aprepitant
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- GrapeModerate
- + 155 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.